Theralase Technologies Inc. V.TLT

New patients coming

[Kingpin68]

Seems like they may have slowed down new enrollments to use their limited resources on getting the data and pre-BTD ready. Plus, now they can treat patients at any time, so perhaps they focused on treatments at 270 or 360 days to boost CR numbers. I guess we'll eventually see. I'm sure they've been working hard to please the FDA.

[DJDawg]

Having worked in a different area of patient recruitement I'm wondering if the slower recruitement was partly due to not having the funds for on the ground staff to meet with patients in the clinic. The way the well funded studies I've seen go is that there is a local assistant hired to touch based with the MD before patients arrive and ask if anyone is a candidate basedon diagnosis. They

[greaterfoolFred]

When did the company tell us that longer followup was needed for BTD?  I don't think that has been mentioned as a requirement.

[plantrader]

@DJ, doesn't this theory have many potential implications?  "My suspicion is that they MDs were willing to do this for a while but that the novelty wore off. That may have been the massive slowdownin in recruitment." Could the novelty really wear off with a treatment that supposedly works better than anything else on the market at this time? Wouldn't they almost be

[O12009]

Of course it's about the money. BTD should happen early 3rd quarter sending stock price to 2 dollars which will activate the need to exercise the August warrants bringing in 57 million dollars. This will fund the rest of the patients by the end of 2024. It will also fund the phase 1 trails on GBM and lung cancer,both greatly needed. On hold the best is yet to come.

[Alamir1111]

TORONTO, ON / ACCESSWIRE / August 22, 2019 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV: TLT) (OTCQB: TLTFF), is pleased to announce the closing of its marketed short form prospectus offering pursuant to which the Company issued 57,500,000 units of the Company (including the exercise in full of the over-allotment option) (the “Units”) at a price of $0.30

[Dumbeldorfwhite]

Always an excuse from the good ole boys, they had recruitment issues when the had 22 milly in the bank, yet they blew through that "trials paid for broooo"

[O12009]

I stand correct approximately 20 million when warrants are exercised.

[DJDawg]

I could be wrong but the way clinics work is that the MDs are always behind and often pick the easiest path in front of them. Most studies I have been part of got very low recruitement unless the company sent in someone to make it happen. BTW the easiest path is to just sign them up for never ending gem/doc or a nother round of BCG if you have it. Or just tell the patient to go to cystectomy. Most

[Alamir1111]

am excited to see the PIVOT-006 study get underway in the intermediate-risk NMIBC population with cretostimogene, a highly selective oncolytic immunotherapy,” said Neal D. Shore, MD, FACS, the Medical Director for the Carolina Urologic Research Center in Myrtle Beach, South Carolina. “Novel treatment options and clinical trials are essential in NMIBC, particularly in this group of underserved

[Dumbeldorfwhite]

Quit spamming the board with nonsense

[Oilminerdeluxe]

And as you say taht, you spam the board with THREE messages. Clown.

[riverrrow]

I want to believe that it quickly became apparent that  the post 450 day data is so spectacular that BTD and more was a given and no more patients needed to be enrolled.  The problem with that dream is TLT hiring of Dr. Michael Jewett in February of 2024 to help complete enrollment.  TLT needs some great news and soon to drive the next inevitable financing.  GLTA.